x
Filter:
Filters applied
- Opioids
- nonsteroidal anti-inflammatory drugRemove nonsteroidal anti-inflammatory drug filter
- GFRRemove GFR filter
Opioids
3 Results
- Review
Drug Management in the Elderly Adult With Chronic Kidney Disease: A Review for the Primary Care Physician
Mayo Clinic ProceedingsVol. 90Issue 5p633–645Published online: March 12, 2015- Claudio Ponticelli
- Gabriele Sala
- Richard J. Glassock
Cited in Scopus: 30With advancing age, the functional reserve of many organs tends to decrease. In particular, the lean body mass, the levels of serum albumin, the blood flow to the liver, and the glomerular filtration rate are reduced in elderly individuals and can be further impaired by the concomitant presence of acute or chronic kidney disease. Moreover, patients with kidney disease are often affected by comorbid processes and are prescribed multiple medications. The aging process also modifies some drug interactions, including the affinity of some drugs for their receptor, the number of receptors, and the cell responses upon receptor activation. - REVIEW
Pain Management in the Cirrhotic Patient: The Clinical Challenge
Mayo Clinic ProceedingsVol. 85Issue 5p451–458Published in issue: May, 2010- Natasha Chandok
- Kymberly D.S. Watt
Cited in Scopus: 182Pain management in patients with cirrhosis is a difficult clinical challenge for health care professionals, and few prospective studies have offered an evidence-based approach. In patients with end-stage liver disease, adverse events from analgesics are frequent, potentially fatal, and often avoidable. Severe complications from analgesia in these patients include hepatic encephalopathy, hepatorenal syndrome, and gastrointestinal bleeding, which can result in substantial morbidity and even death. - SUPPLEMENT ARTICLE
Treatment Considerations for Patients With Neuropathic Pain and Other Medical Comorbidities
Mayo Clinic ProceedingsVol. 85Issue 3SupplementS15–S25Published in issue: March, 2010- Maija L. Haanpää
- Geoffrey K. Gourlay
- Joel L. Kent
- Christine Miaskowski
- Srinivasa N. Raja
- Kenneth E. Schmader
- and others
Cited in Scopus: 72The efficacy of drugs for neuropathic pain has been established in randomized controlled trials that have excluded patients with comorbid conditions and those taking complex medications. However, patients with neuropathic pain frequently present with complex histories, making direct application of this evidence problematic. Treatment of neuropathic pain needs to be individualized according to the cause of the pain, concomitant diseases, medications, and other individual factors. Tricyclic antidepressants (TCAs), gabapentinoids, selective noradrenergic reuptake inhibitors, and topical lidocaine are the first-line choices; if needed, combination therapy may be used.